Heidi Dearborn, DO Dermatology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-5350 |
Dr. Christopher M Edens, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-6225 |
Dr. Emily Beth Wong, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-8808 |
Dr. Wendi Wohltmann, M.D. Dermatology - Dermatopathology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-5350 |
Shannon Patrick Buck, D.O. Dermatology - MOHS-Micrographic Surgery Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-8200 Fax: 210-292-3781 |
Jared Eldon Roberts, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-8808 Fax: 210-292-3781 |
Dr. Matthew Micah Malan, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop, Bldg 4554, Attn: 59 Mdw/sghc, Jbsa Lackland, TX 78236 Phone: 210-292-6225 |
Dr. Marie J Han, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-8808 |
News Archive
One of the physiopathological characteristics of COVID-19 that has most baffled the scientific and medical community is what is known as "silent hypoxemia" or "happy hypoxia".
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, and Ludmila Belayev, MD, LSU Health New Orleans Professor of Neuroscience, Neurology and Neurosurgery, has unlocked a key fundamental mechanism in the communication between brain cells when confronted with stroke.
For the twelfth time in 14 years, Loyola University Medical Center has been named one of the nation's Most Wired hospitals.
ISTO Technologies, Inc., an orthobiologics company with a cell-based platform for cartilage regeneration, announced today the completion of patient enrollment in the Phase I clinical study for NuQu™, an injectable formulation of juvenile chondrocytes designed for the treatment of discogenic back pain. The study included 15 patients enrolled at two clinical sites. All patients enrolled in the trial suffered from persistent discogenic back pain and disability despite undergoing previous traditional conservative therapy.
Health and Human Services Secretary Kathleen Sebelius is trying to soothe the fiscal and administrative concerns of officials in states who have considerable power in implementing the nation's attempt at health reform, The Wall Street Journal reports. "The law puts heavy demands on Ms. Sebelius — it has more than 1,000 references to actions that the 'secretary shall' take. But much of the responsibility for actually implementing the changes falls to states, so the Obama administration's top health official has been working to guide them."
› Verified 7 days ago